2023
DOI: 10.1186/s40249-023-01106-y
|View full text |Cite
|
Sign up to set email alerts
|

Molecular epidemiology of hepatitis C virus genotypes in different geographical regions of Chinese mainland and a phylogenetic analysis

Abstract: Background Hepatitis C virus (HCV) infection remains a major public health problem in Chinese mainland. Investigation of the distribution of genotypes contributed to the prevention, diagnosis and treatment of HCV infection. Therefore, we conducted a study on the distribution of HCV genotypes and phylogenetic analysis to provide an up-to-date understanding of the molecular epidemiology of genotypes in Chinese mainland. Methods Our retrospective mult… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
4
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 26 publications
3
4
0
Order By: Relevance
“…In our study, we found that the predominant HCV subtypes among drug users in Zhuhai, a port city in Guangdong Province in China, were 6a (60.26%), followed by 3b (16.7%) and 3a (12.8%), respectively. This predominance of the 6a subtype in Zhuhai is consistent with previous reports, as 6a was mainly prevalent in South China, like the Guangdong and Guangxi provinces [ 9 , 31 ]. The genotype GT3 (3a and 3b) primarily circulated in Southwest China, like Yunnan province, and East Asian countries, where drug smuggling and intravenous drug abuse were prevalent [ 9 , 31 33 ].…”
Section: Discussionsupporting
confidence: 92%
See 2 more Smart Citations
“…In our study, we found that the predominant HCV subtypes among drug users in Zhuhai, a port city in Guangdong Province in China, were 6a (60.26%), followed by 3b (16.7%) and 3a (12.8%), respectively. This predominance of the 6a subtype in Zhuhai is consistent with previous reports, as 6a was mainly prevalent in South China, like the Guangdong and Guangxi provinces [ 9 , 31 ]. The genotype GT3 (3a and 3b) primarily circulated in Southwest China, like Yunnan province, and East Asian countries, where drug smuggling and intravenous drug abuse were prevalent [ 9 , 31 33 ].…”
Section: Discussionsupporting
confidence: 92%
“…This predominance of the 6a subtype in Zhuhai is consistent with previous reports, as 6a was mainly prevalent in South China, like the Guangdong and Guangxi provinces [ 9 , 31 ]. The genotype GT3 (3a and 3b) primarily circulated in Southwest China, like Yunnan province, and East Asian countries, where drug smuggling and intravenous drug abuse were prevalent [ 9 , 31 33 ]. Surprisingly, the prevalence of genotype GT3 was also remarkably high among drug users in Zhuhai, reaching approximately 30%.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…Subtype 2a, once predominantly transmitted through contaminated blood transfusions prior to the 1900s, has seen a decline in prevalence after the 1992 ban on paid blood donations, but it remains to be one of the most prevalent subtypes alongside subtype 1b. Conversely, subtypes 3a, 3b, and 6a, associated with injection drug use, have increased, according to recent studies [12]. Shaanxi province had less diversi ed genotype distribution patterns compared to southern Chinese provinces, with subtype 2a being particularly prevalent [5,[12][13].…”
Section: Discussionmentioning
confidence: 99%
“…While nosocomial transmission is now effectively controlled, the challenges persist in controlling transmission among individuals engaged in drug use and those involved in high-risk sexual behaviors [ 11 , 12 ]. The majority of this population is infected with subtypes 3 and 6 [ 13 15 ], signifying that patients with genotype 3b will account for an increased proportion of patients with hepatitis C in the future [ 16 ]. Using pan-genotypic regimens may not be the best choice for 3b patients, but the process of identifying these patients imposes time and testing costs on non-3b patients.…”
Section: Introductionmentioning
confidence: 99%